There is an urgent need for precision immunotherapy strategies that simultaneously target both tumor cells and immune cells to enhance treatment efficacy. Identifying genes with dual functions in both cancer and immune cells opens new possibilities for overcoming tumor resistance and improving patient survival.
Gene therapy, a technique that is revolutionizing the treatment of multiple genetic conditions, including eye and muscle diseases and blood disorders, requires efficient and specific delivery of the genetic material to the tissue and cell type of interest.
Hundreds of U.S. research projects aimed at boosting vaccine confidence have been shut down—just as preventable diseases like measles and flu are on the rise.
Most people donning virtual reality (VR) goggles are seeking the thrill of being immersed in a fictitious video game world. But some are donning them for an entirely different experience: to help researchers identify those most at risk of developing Alzheimer’s disease.
In military service members with a history of repetitive blast exposure, researchers found that higher blast exposure correlated with changes in the functional connectivity between brain regions, according to a new study published in Radiology.
Blood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 vaccinations, a new study suggests.
A new interdisciplinary study by researchers from the Ruth and Bruce Rappaport Faculty of Medicine and the Andrew and Erna Viterbi Faculty of Electrical and Computer Engineering at the Technion reveals a surprising insight: local release of dopamine—a molecule best known for its role in the brain’s reward system—is a key factor in acquiring new motor skills
In mice, autism symptoms arise when a certain pair of competing nerve proteins falls out of equilibrium, according to a study published in the open-access journal PLOS Biology by Dongdong Zhao of Wenzhou Medical University, China, Yun-wu Zhang of Xiamen University, China, and colleagues.
In his new book, No More Normal, psychiatrist Alastair Santhouse recalls an experience from the 1980s when he was a university student in the UK helping deliver supplies to “refuseniks”—Soviet citizens who were denied permission to leave the USSR. These people often faced harsh treatment, losing their jobs and becoming targets of harassment. Some were even diagnosed with a psychiatric condition called “sluggish schizophrenia.”
Scientists have taken an important step toward the development of a potential new treatment for treating Shiga toxin-producing E. coli (STEC), the notorious bug associated with severe food poisoning.